Deutsche Börse

(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release →

(IN BRIEF) Vonovia SE will propose Michael Rüdiger and Dr Marcus Schenck for election to its Supervisory Board at the 2025 Annual General Meeting, replacing Dr Ute Geipel-Faber and Hildegard Müller. Both nominees bring decades of leadership in the financial … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. have announced a significant global supply agreement aimed at supporting AtomVie’s radiopharmaceutical manufacturing efforts. Under this agreement, Eckert & Ziegler will provide its high-grade non-carrier added Lutetium-177 chloride (Theralugand®) … Read the full press release →

(IN BRIEF) The venture capital landscape is evolving as priorities shift, with climate technology losing some of its earlier momentum while sectors like cybersecurity, artificial intelligence, and defense see increased investment interest. Young businesses focused on these areas are expected … Read the full press release →

(IN BRIEF) A new report from Market Structure Partners (MSP) reveals that European stock exchanges are increasingly relying on market data sales to offset declining trading revenues, resulting in rising costs for equity market data. Despite reduced trading volumes, exchanges … Read the full press release →

(IN BRIEF) Eckert & Ziegler and Ariceum Therapeutics have signed a global supply agreement for critical medical radionuclides Actinium-225 (Ac-225) and Lutetium-177 (Lu-177). The radionuclides will be used in Ariceum’s lead radiopharmaceutical drug, satoreotide, targeting hard-to-treat cancers such as small … Read the full press release →

(IN BRIEF) The European Commission has approved Theralugand®, Eckert & Ziegler’s high-purity Lutetium-177 chloride, for routine clinical use across the European Economic Area. This approval allows its application in targeted cancer therapies, such as for neuroendocrine tumors and metastatic prostate … Read the full press release →

(IN BRIEF) Encavis AG has successfully fulfilled all conditions for its voluntary public takeover by Elbe BidCo AG, a KKR-led consortium, which now holds 87.73% of Encavis shares after acquiring 87.41% at EUR 17.50 per share. The partnership, formalized through … Read the full press release →

(IN BRIEF) Schouw & Co., a Danish industrial conglomerate, has entered into a 10-year Power Purchase Agreement (PPA) with ENCAVIS AG, a renewable energy provider in Germany, to power its European operations with green energy. Beginning in 2025, Schouw & … Read the full press release →

(IN BRIEF) Commerzbank has partnered with Crypto Finance, a subsidiary of Deutsche Börse, to offer secure access to digital assets, specifically bitcoin and ether, for its corporate clients in Germany. Commerzbank will handle crypto asset custody, while Crypto Finance manages … Read the full press release →

(IN BRIEF) Encavis AG has secured €61 million in project financing for its 114 MW Borrentin solar park in Germany. The financing was provided by Bayerische Landesbank and will help complete the solar park by the end of September 2024. … Read the full press release →

(IN BRIEF) Eckert & Ziegler has signed a multi-year agreement with Telix Pharmaceuticals to serve as the European contract manufacturing organization for Telix’s ProstACT GLOBAL Phase III study. The agreement includes supplying patients from Eckert & Ziegler’s Berlin facility and … Read the full press release →

(IN BRIEF) Lebohang Kganye has been awarded the esteemed £30,000 photography prize for her groundbreaking exhibition “Haufi nyana? I’ve come to take you home” at Foam, Amsterdam. Combining various artistic mediums, Kganye’s work delves into personal and familial histories in … Read the full press release →

(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its GC Pooling segment, aimed at enhancing liquidity and efficiency in the European repo market for green bonds. This addition expands upon the existing three Green … Read the full press release →

(IN BRIEF) LPKF Laser & Electronics SE achieved its Q1 revenue of EUR 25.4 million and adjusted EBIT of EUR -4.3 million, meeting guidance despite challenges in incoming orders due to project delays. The company made strides in key areas, … Read the full press release →

(IN BRIEF) LPKF Laser & Electronics SE disclosed its financial performance for the fiscal year, registering a revenue of EUR 124.3 million and an EBIT of EUR 3.7 million, slightly lower than the previous year’s figures. Despite facing challenges such … Read the full press release →

(IN BRIEF) Douglas AG (ISIN: DE000BEAU7Y1) marks a significant milestone as it joins the Prime Standard of the Frankfurt Stock Exchange, commencing trading with an initial listing price of EUR 25.50. The company’s IPO, led by Citigroup, Goldman Sachs, and … Read the full press release →

(IN BRIEF) In a significant development, LPKF Laser & Electronics SE has secured another major order in the solar market, reaffirming its longstanding partnership with a prominent international manufacturer. The order entails the supply of high-precision laser systems for structuring … Read the full press release →

(IN BRIEF) The Deutsche Börse Digital Exchange (DBDX) has commenced trading activities with successful transactions facilitated by ICF Bank and Bankhaus Metzler, marking a significant milestone in the institutional adoption of blockchain technology in the financial sector. With a focus … Read the full press release →

(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release →